Reversing Course on Reverse Payment Settlements in the Pharmaceutical Industry: Has Schering-Plough Created the Blueprint for Defensible Antitrust Violations?

Authors

Scott A. Backus, University of Oklahoma, College of LawFollow

Recommended Citation

Scott A. Backus, Reversing Course on Reverse Payment Settlements in the Pharmaceutical Industry: Has Schering-Plough Created the Blueprint for Defensible Antitrust Violations?, 60 Okla. L. Rev. 375 (2007),
https://digitalcommons.law.ou.edu/olr/vol60/iss2/4